Medicine guide

VYNDAQEL

As listed in the register: VYNDAQEL 61 mg, capsule molle

61 mg · capsule molle

  • Prescription only
Active substance
Tafamidis
Made by
PFIZER EUROPE MA EEIG (BELGIQUE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

Details

Made byPFIZER EUROPE MA EEIG (BELGIQUE)
Active substanceTafamidis
Strength61 mg
Formcapsule molle
Routeorale
Dispensing (as stated by the register)prescription initiale hospitalière · liste I · prescription initiale annuelle réservée aux spécialistes et services CARDIOLOGIE · renouvellement non restreint
MarketedYes, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/11/717
Name in the registerVYNDAQEL 61 mg, capsule molle
Packsplaquettes PVC polyamide aluminium PVC-Aluminium de 30 x 1 capsules (conditionnement unitaire)
CIS61420887
CIP133400930202074

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

  • capsule molle2 products